The anticipated end of the COVID public health emergency will bring a massive change in how patients receive prescriptions for drugs like Adderall, Xanax and hormone therapies, by requiring them to see a doctor in person.
Why it matters: The pandemic-fueled explosion in telehealth — and policies to enable it — removed such requirements, and providers warn that an abrupt return to the old way of dispensing controlled substances with medical uses could be hugely disruptive.
